We are live on ! Find out more
OGEN icon

Oragenics

10 hedge funds and large institutions have $18.5M invested in Oragenics in 2014 Q3 according to their latest regulatory filings, with 2 funds opening new positions, 1 increasing their positions, 1 reducing their positions, and 0 closing their positions.

New
Increased
Maintained
Reduced
Closed

25% more funds holding

Funds holding: 810 (+2)

0% more funds holding in top 10

Funds holding in top 10: 11 (0)

0% more ownership

Funds ownership: 0%0% (+0%)

0% more repeat investments, than reductions

Existing positions increased: 1 | Existing positions reduced: 1

36% less capital invested

Capital invested by funds: $28.8M → $18.5M (-$10.3M)

Holders
10
Holders Change
+2
Holders Change %
+25%
% of All Funds
0.29%
Holding in Top 10
1
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.03%
New
2
Increased
1
Reduced
1
Closed
Calls
Puts
Net Calls
Net Calls Change

OGEN Hedge Fund Activity: Q3 2014 in Review

10 of the 3,447 institutional investors tracked by Wall St. Rank reported a position in Oragenics (OGEN) for Q3 2014, worth a combined $18.5M — down 36% from $28.8M a quarter earlier.

Buyers outnumbered sellers: 2 funds opened new OGEN positions and 0 closed out — a net gain of 2 holders — while 1 added to existing stakes and 1 trimmed.

The largest buyer was Jacobs Levy Equity Management, opening a new position worth an estimated $59.7K. The largest seller was Janney Montgomery Scott, cutting an estimated $29.8K.

  • 10 institutional investors held Oragenics (OGEN) as of Q3 2014, up from 8 in Q2 2014.
  • Funds reported $18.5M of Oragenics stock for Q3 2014, down 36% quarter-over-quarter.
  • 2 funds opened new Oragenics positions in Q3 2014 and 0 closed out, a net change of +2 holders.
  • The largest Oragenics buyer in Q3 2014 was Jacobs Levy Equity Management, an estimated $59.7K added.
  • The largest Oragenics seller in Q3 2014 was Janney Montgomery Scott, an estimated $29.8K sold.

Based on aggregated 13F filings for Q3 2014.